GATTI, GIULIANA
 Distribuzione geografica
Continente #
NA - Nord America 2.109
AS - Asia 1.514
EU - Europa 1.263
SA - Sud America 157
AF - Africa 83
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.129
Nazione #
US - Stati Uniti d'America 2.067
CN - Cina 762
IE - Irlanda 333
SG - Singapore 321
HK - Hong Kong 170
UA - Ucraina 154
DE - Germania 138
FI - Finlandia 138
RU - Federazione Russa 130
BR - Brasile 117
VN - Vietnam 99
SE - Svezia 83
GB - Regno Unito 79
IT - Italia 72
FR - Francia 59
ZA - Sudafrica 56
IN - India 42
CA - Canada 27
BD - Bangladesh 21
BE - Belgio 20
JP - Giappone 18
AR - Argentina 16
PL - Polonia 14
IQ - Iraq 12
MX - Messico 11
TR - Turchia 11
ES - Italia 10
ID - Indonesia 9
PK - Pakistan 9
NL - Olanda 8
LT - Lituania 6
MA - Marocco 6
VE - Venezuela 6
CO - Colombia 5
CZ - Repubblica Ceca 5
MY - Malesia 5
SA - Arabia Saudita 5
TN - Tunisia 5
AT - Austria 4
EC - Ecuador 4
KR - Corea 4
PY - Paraguay 4
AM - Armenia 3
BY - Bielorussia 3
DZ - Algeria 3
JO - Giordania 3
PH - Filippine 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BJ - Benin 2
CL - Cile 2
CR - Costa Rica 2
EE - Estonia 2
EG - Egitto 2
KE - Kenya 2
MU - Mauritius 2
OM - Oman 2
TH - Thailandia 2
TJ - Tagikistan 2
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NE - Niger 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.129
Città #
Dublin 333
Chandler 278
Dallas 243
Jacksonville 201
Singapore 190
Ashburn 168
Hong Kong 168
Nanjing 159
Beijing 154
San Jose 153
Ann Arbor 82
Boardman 75
Los Angeles 68
Johannesburg 55
Princeton 52
Changsha 51
Lawrence 50
Nanchang 50
Lauterbourg 45
Wilmington 45
Shenyang 40
Ho Chi Minh City 38
Helsinki 34
Hebei 33
Jiaxing 31
Munich 31
Tianjin 31
Medford 28
Shanghai 28
Redondo Beach 24
Buffalo 23
Hanoi 23
Woodbridge 23
Hangzhou 20
Moscow 20
Brussels 19
Milan 17
New York 17
São Paulo 17
Tokyo 17
London 15
Brooklyn 14
Orem 14
Houston 13
Chicago 12
The Dalles 12
Turku 12
Chennai 11
Frankfurt am Main 11
Warsaw 11
Montreal 9
Pavia 9
Pune 9
San Francisco 9
Denver 8
Des Moines 8
Atlanta 7
Columbus 7
Santa Clara 7
Toronto 7
Zhengzhou 7
Da Nang 6
Guangzhou 6
Manchester 6
Stockholm 6
Verona 6
Baghdad 5
Fairfield 5
Istanbul 5
Jakarta 5
Mexico City 5
New Delhi 5
Norwalk 5
Palermo 5
Seattle 5
Taizhou 5
Amsterdam 4
Dhaka 4
Nuremberg 4
Piscataway 4
Poplar 4
Rome 4
Asunción 3
Berlin 3
Boston 3
Brno 3
Charlotte 3
City of London 3
Cologno Monzese 3
Guarulhos 3
Kansas City 3
Minsk 3
Ottawa 3
Phoenix 3
Radomsko 3
Rio de Janeiro 3
Shijiazhuang 3
Tashkent 3
Tunis 3
Valencia 3
Totale 3.504
Nome #
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 166
A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. 161
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 158
A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. 152
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 151
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbamazepine in healthy women 150
A Double-Blind, Placebo-Controlled Study on the Effect of Vigabatrin on In Vivo Parameters of Hepatic Microsomal Enzyme Induction and on the Kinetics of Steroid Oral Contraceptives in Healthy Female Volunteers 142
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and puerperium. 138
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 127
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 125
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 121
Clinical pharmacokinetics of fluvoxamine. 118
Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography 118
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. 116
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.SOPHIE Study Group. 114
Omeprazole Does Not Enhance the Metabolism of Phenacetin, a Marker of CYP1A2 Activity, in Healthy Volunteers 113
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 112
Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects. 112
The new antiepileptic drugs: Pharmacological and clinical aspects. 105
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy 104
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. 103
Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. 103
Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study. 102
DIFFERENTIAL-EFFECTS OF VALPROIC ACID AND ENZYME-INDUCING ANTICONVULSANTS ON NIMODIPINE PHARMACOKINETICS IN EPILEPTIC PATIENTS 102
Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey. 99
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine. 99
CYP2D6-related oxidation polymorphism in Italy 96
Farmacocinetica delle benzodiazepine. 95
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 94
Plasma gabapentin concentrations in children with epilepsy: Influence of age, relationship with dosage, and preliminary observations on correlation with clinical response 93
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 92
Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy 92
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy 92
The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic Children 90
Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. 90
Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. 89
Pharmacokinetic and metabolic investigation of topiramate disposition in healthy subjects in the presence and absence of enzyme induction by carbamazepine. 88
The Influence of Ethnic Factors and Gender on CYP1A2-Mediated Drug Disposition: A Comparative Study in Caucasian and Chinese Subjects Using Phenacetin as a Marker Substrate 88
Challenges in the pharmacotherapy of the epilepsies 86
Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability. 84
The disposition of theophylline in patients with lung and breast cancer. 82
Reduced Plasma Nisoldipine Concentrations in Phenytoin-Treated Patients with Epilepsy 77
Protective effect of cyanidin (IdB 1027) against aspirin-induced fall in gastric transmucosal potential difference in normal subjects. 76
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid. 73
Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response. 72
Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers. 72
Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy 72
Pharmacokinetic and pharmacodynamic studies following single and multiple doses of rolafagrel, a novel inhibitor of thromboxane synthase, in normal volunteers 64
The disposition of primidone in elderly patients. 63
Possible enhancement of the first-pass metabolism of prenacetin by grape juice in Chinese subjects 49
Totale 5.180
Categoria #
all - tutte 19.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 50 40 19
2021/2022210 10 2 4 7 2 6 5 12 13 8 37 104
2022/2023849 91 74 7 53 76 81 0 57 374 4 19 13
2023/2024247 46 40 5 19 25 50 4 23 3 7 12 13
2024/2025763 34 60 17 26 7 58 26 37 185 29 110 174
2025/20261.781 142 216 243 163 215 95 350 120 156 81 0 0
Totale 5.180